TOPOTECAN IN THE SECOND-LINE AND THIRD-LINE TREATMENT OF OVARIAN CANCER. Issue 1 (1st March 2003) - Taskiran, C.; Yigit, N.; Tuncer, S. Z.; Yuce, K.; Ayhan, A.